Test Price
2,600 AED✅ Home Collection Available
4H Syndrome Genetic Sequencing Test – 2,600 AED – DNA Labs UAE
Executive Summary & Core Performance Metrics
This advanced genetic sequencing test provides a definitive molecular diagnosis for 4H Syndrome (Hypomyelination, Hypodontia, Hypogonadotropic Hypogonadism) using next-generation sequencing (NGS) technology with orthogonal Sanger confirmation, delivering a diagnostic accuracy of over 99.9%. Processing is performed exclusively at our ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139), ensuring stringent quality control. We offer a comprehensive service package including VIP mobile phlebotomy, temperature-controlled cold-chain logistics, and a complimentary post-test tele-counseling session with a DHA-licensed clinical geneticist.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed physician.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Diagnostic Methodology
The 4H Syndrome Genetic Sequencing Test is a targeted next-generation sequencing (NGS) panel with orthogonal Sanger confirmation, designed to identify pathogenic variants in POLR3A, POLR3B, and related genes associated with hypomyelination, hypodontia, and hypogonadotropic hypogonadism. This molecular diagnostic approach enables precise genetic characterization, allowing physicians to confirm the diagnosis, predict disease progression, and tailor early therapeutic interventions.
| Feature | Our Test (NGS + Sanger) | Closest Alternative (Single‑Gene Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity; full gene coverage with copy number variant detection | Limited to preselected exons; may miss rare or novel variants |
| Method | NGS with orthogonal Sanger validation (LC‑MS/MS‑free) | Sanger only; no parallel multi‑gene screening capability |
| Turnaround Time | 40 working days (comprehensive report) | 8–12 weeks for sequential single-gene testing |
Physician Insight & Mandatory Safety Protocols
“This test provides a highly accurate molecular diagnosis for 4H syndrome. However, clinical correlation by a paediatric neurologist or clinical geneticist is mandatory for comprehensive interpretation. A negative NGS result does not completely exclude the presence of a pathogenic variant. All findings must be rigorously contextualized within the patient’s neurological, dental, and endocrine presentation. Pre- and post-test genetic counselling is strongly recommended.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication & Clinical Management Advisory
Critical Medication Advisory
Do not alter or discontinue any prescribed therapeutic regimen without explicit consultation with your treating physician. This genetic diagnostic test is an elective procedure and does not substitute for acute medical care or ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- This test is intended exclusively for patients with a clinical suspicion of 4H syndrome. It is not validated for population screening or asymptomatic individuals without a specific clinical indication.
- Patients presenting with acute neurological deterioration, status epilepticus, or respiratory compromise must receive immediate emergency medical intervention; elective genetic testing must be deferred until the patient is clinically stable.
- If the patient has severe anaemia, compromised venous access, or a history of vasovagal syncope, alternative sampling arrangements must be coordinated with our clinical logistics team prior to scheduling the home collection.
Patient FAQ & Clinical Guidance
1. What is 4H syndrome and how does this genetic test help?
4H syndrome is a rare genetic disorder characterized by hypomyelination (delayed brain white matter development), hypodontia (missing or malformed teeth), and hypogonadotropic hypogonadism (delayed or absent puberty due to hormone deficiency). This sequencing test identifies pathogenic variants in the POLR3A, POLR3B, and related genes, providing a definitive molecular diagnosis that enables clinicians to predict disease progression and initiate targeted management strategies early.
2. How is the blood sample collected and what consent is required?
A trained VIP mobile phlebotomist will collect 10 mL of whole blood into two lavender-top EDTA tubes. The sample is transported under strict temperature-controlled cold-chain conditions. A mandatory Whole Exome Sequencing Consent Form (Form 37) must be signed by the patient or legal guardian, in full compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full transparency and ethical consent protocols.
3. When will I receive the results and is there post-test support?
The comprehensive genetic report is issued within 40 working days. After receiving your report, you may schedule a complimentary tele-counseling session with a DHA-licensed specialist to discuss the clinical implications of the findings and outline the recommended next steps for patient management.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with all applicable UAE federal laws governing health data and personal privacy. All genetic data is encrypted during transmission and storage, with access restricted to authorized clinical personnel only. Our operations adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | 4H Syndrome Genetic Sequencing Test (NGS + Sanger Confirmation) |
| Price (AED) | 2,600 AED |
| Turnaround Time | 40 Working Days |
| Sample Type / Matrix | Whole Blood (10 mL in Lavender-top EDTA Tubes) |
| Methodology Used | Next-Generation Sequencing (NGS) with Orthogonal Sanger Validation |
| ICD-10-CM Code | E23.0, G37.8, K00.0 |
| LOINC Code | 51961-7 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians